691 related articles for article (PubMed ID: 11160820)
1. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism.
Bhowmick NA; Ghiassi M; Bakin A; Aakre M; Lundquist CA; Engel ME; Arteaga CL; Moses HL
Mol Biol Cell; 2001 Jan; 12(1):27-36. PubMed ID: 11160820
[TBL] [Abstract][Full Text] [Related]
2. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
Wang D; Shen Q; Chen YQ; Wang MH
Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985
[TBL] [Abstract][Full Text] [Related]
3. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.
Zhao BM; Hoffmann FM
Mol Biol Cell; 2006 Sep; 17(9):3819-31. PubMed ID: 16775010
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition.
Valcourt U; Kowanetz M; Niimi H; Heldin CH; Moustakas A
Mol Biol Cell; 2005 Apr; 16(4):1987-2002. PubMed ID: 15689496
[TBL] [Abstract][Full Text] [Related]
7. Smad3 regulates Rho signaling via NET1 in the transforming growth factor-beta-induced epithelial-mesenchymal transition of human retinal pigment epithelial cells.
Lee J; Moon HJ; Lee JM; Joo CK
J Biol Chem; 2010 Aug; 285(34):26618-27. PubMed ID: 20547485
[TBL] [Abstract][Full Text] [Related]
8. RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability.
Clements RT; Minnear FL; Singer HA; Keller RS; Vincent PA
Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L294-306. PubMed ID: 15475381
[TBL] [Abstract][Full Text] [Related]
9. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
Maeda M; Shintani Y; Wheelock MJ; Johnson KR
J Biol Chem; 2006 Jan; 281(1):59-68. PubMed ID: 16267045
[TBL] [Abstract][Full Text] [Related]
10. Hic-5 contributes to epithelial-mesenchymal transformation through a RhoA/ROCK-dependent pathway.
Tumbarello DA; Turner CE
J Cell Physiol; 2007 Jun; 211(3):736-47. PubMed ID: 17299801
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro.
Wang QL; Tao YY; Yuan JL; Shen L; Liu CH
BMC Cell Biol; 2010 May; 11():31. PubMed ID: 20441599
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1-mediated alterations of renal proximal tubular epithelial cell phenotype.
Tian YC; Fraser D; Attisano L; Phillips AO
Am J Physiol Renal Physiol; 2003 Jul; 285(1):F130-42. PubMed ID: 12644442
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.
Miettinen PJ; Ebner R; Lopez AR; Derynck R
J Cell Biol; 1994 Dec; 127(6 Pt 2):2021-36. PubMed ID: 7806579
[TBL] [Abstract][Full Text] [Related]
14. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity.
Bhowmick NA; Zent R; Ghiassi M; McDonnell M; Moses HL
J Biol Chem; 2001 Dec; 276(50):46707-13. PubMed ID: 11590169
[TBL] [Abstract][Full Text] [Related]
15. LIM-kinase 2 and cofilin phosphorylation mediate actin cytoskeleton reorganization induced by transforming growth factor-beta.
Vardouli L; Moustakas A; Stournaras C
J Biol Chem; 2005 Mar; 280(12):11448-57. PubMed ID: 15647284
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation.
Lu Q; Harrington EO; Jackson H; Morin N; Shannon C; Rounds S
J Appl Physiol (1985); 2006 Aug; 101(2):375-84. PubMed ID: 16645187
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes.
Grände M; Franzen A; Karlsson JO; Ericson LE; Heldin NE; Nilsson M
J Cell Sci; 2002 Nov; 115(Pt 22):4227-36. PubMed ID: 12376555
[TBL] [Abstract][Full Text] [Related]
18. Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro.
Xie L; Law BK; Chytil AM; Brown KA; Aakre ME; Moses HL
Neoplasia; 2004; 6(5):603-10. PubMed ID: 15548370
[TBL] [Abstract][Full Text] [Related]
19. Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway.
Das S; Becker BN; Hoffmann FM; Mertz JE
BMC Cell Biol; 2009 Dec; 10():94. PubMed ID: 20025777
[TBL] [Abstract][Full Text] [Related]
20. A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation.
Kondo M; Cubillo E; Tobiume K; Shirakihara T; Fukuda N; Suzuki H; Shimizu K; Takehara K; Cano A; Saitoh M; Miyazono K
Cell Death Differ; 2004 Oct; 11(10):1092-101. PubMed ID: 15181457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
